Shares of Avanos Medical AVNS rose 0.1% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were down 17.65% year over year to $0.28, which beat the estimate of $0.22.
Revenue of $185,000,000 declined by 2.53% year over year, which beat the estimate of $184,150,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: Feb 18, 2021
Time: 09:00 AM
ET Webcast URL: https://www.webcaster4.com/Webcast/Page/939/39729
Price Action
52-week high: $53.40
Company's 52-week low was at $19.46
Price action over last quarter: Up 31.75%
Company Profile
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.